SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology
0 references·7 citing·30 second hop
Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology (2002)Implementation of donor screening for inf…International review of blood donation nucleic acid amplification testing (2024)International review of blood…Automated nucleic acid amplification testing in blood banks: An additional layer of blood safety (2015)Automated nucleic acid amplif…Trends in Transfusion Transmitted Infections Among Replacement Blood Donors in Karachi, Pakistan (2013)Trends in Transfusion Transmi…Magnetic bead technology for viral RNA extraction from serum in blood bank screening (2011)Magnetic bead technology for …Nucleic acid technology screening of Australian blood donors for hepatitis C and human immunodeficiency virus‐1 RNA: comparison of two high‐throughput testing strategies (2003)Nucleic acid technology scree…Health and economic impact of posttransfusion hepatitis B and cost‐effectiveness analysis of expanded HBV testing protocols of blood donors: a study focused on the European Union (2003)Health and economic impact of…Nucleic acid amplification technology methods used in blood donor screening (2002)Nucleic acid amplification te…Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting (1999)Failure of Routine HIV-1 Tests in a Case Involving Transmission With Preseroconversion Blood Components During the Infectious Window Period (2000)NAT of the United States and Canadian blood supply (2000)Screening of Blood Donations for HIV-1 and HCV RNA by Transcription-Mediated Amplification Assay: One Year Experience (2004)Estimating the risk of blood donation associated with HIV risk behaviours (2008)Nucleic acid amplification testing of blood donors fortransfusion‐transmitted infectious diseases (2000)Current prevalence and incidence of infectious disease markers and estimated window‐period risk in the American Red Cross blood donor population (2002)Residual risk of transmission of human immunodeficiency virus and hepatitis C virus infections by blood transfusion in northern Brazil (2017)Three-Year Experience in NAT Screening of Blood Donors for Transfusion Transmitted Viruses in Croatia (2017)Assessment of Blood Donation and Transfusion in Eastern Uganda: A Mixed-Methods Study (2019)Estimates of the frequency of HBV, HCV, and HIV infectious donations entering the blood supply in the United Kingdom, 1996 to 2003 (2005)Seroprevalence of HIV, HBV, HCV and syphilis in blood donors in Southern Haryana (2010)Moving on from voluntary non‐remunerated donors: who is the best blood donor? (2011)Changing trends in seroprevalence rates of transfusion-transmitted diseases among blood donors in Jordan (2021)A convenient approximation of life expectancy (the “DEALE”) (1982)The Markov Process in Medical Prognosis (1983)Simulation modeling and analysis (1999)Seroepidemiologic Study of Hepatitis B Virus, Hepatitis C Virus, Human Immunodeficiency Virus and Syphilis Infections in Iranian Blood Donors (2007)Cost‐effectiveness of additional hepatitis B virus nucleic acid testing of individual donations or minipools of six donations in the Netherlands (2008)The Measurement of Observer Agreement for Categorical Data (1977)The cost‐effectiveness of NAT for HIV, HCV, and HBV in whole‐blood donations (2003)Detection of HIV-1 and HCV Infections among Antibody-Negative Blood Donors by Nucleic Acid–Amplification Testing (2004)The Risk of Transfusion-Transmitted Viral Infections (1996)Application de la biologie moléculaire à la sécurité virale transfusionnelle : le dépistage génomique viral (2003)The mantra of blood safety: time for a new tune? (2004)HIV-1, HCV and HBV seronegative window reduction by the new Roche cobas® TaqScreen MPX test in seroconverting donors (2007)A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donors (2005)International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009 (2011)Prevention of transfusion-transmitted infections (2019)International review of blood donation screening for anti‐HBc and occult hepatitis B virus infection (2024)
this work references cited by second hop

References

No references inside the corpus for this window.

Cited by

  • 2015Automated nucleic acid amplification testing in blood banks: An additional layer of blood safety36 cited
  • 2003Health and economic impact of posttransfusion hepatitis B and cost‐effectiveness analysis of expanded HBV testing protocols of blood donors: a study focused on the European Union34 cited
  • 2002Nucleic acid amplification technology methods used in blood donor screening33 cited
  • 2024International review of blood donation nucleic acid amplification testing29 cited
  • 2013Trends in Transfusion Transmitted Infections Among Replacement Blood Donors in Karachi, Pakistan21 cited
  • 2003Nucleic acid technology screening of Australian blood donors for hepatitis C and human immunodeficiency virus‐1 RNA: comparison of two high‐throughput testing strategies16 cited
  • 2011Magnetic bead technology for viral RNA extraction from serum in blood bank screening9 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work